For problematic papers, don’t retract or correct, say publishing experts: Amend

A group of publishing experts have proposed a somewhat radical idea: Instead of retracting papers, or issuing corrections that address problems, authors should amend published articles. Here’s how it would work – any post-publication changes would be added as amendments labeled “insubstantial,” “substantial,” or “complete” (equivalent to a retraction). Is this a better way? We spoke with authors of a preprint in BioRxiv — Virginia Barbour, chair of the Committee on Publication Ethics (COPE); Theodora Bloom, executive editor of The BMJ; Jennifer Lin, director of product management at Crossref; and Elizabeth Moylan, senior editor of research integrity at BioMed Central.

Retraction Watch: Why do you think it’s a good idea to amend articles, rather than issue formal retractions or corrections?

Continue reading For problematic papers, don’t retract or correct, say publishing experts: Amend

“Failure is an essential part of science:” A Q&A with the author of a new book on reproducibility

Reproducibility is everywhere recently, from the pages of scientific journals to the halls of the National Academy of Sciences, and today it lands in bookstores across the U.S. Longtime NPR correspondent Richard Harris has written Rigor Mortis (Basic Books), which is published today. (Full disclosure: I blurbed the book, writing that “Harris deftly weaves gripping tales of sleuthing with possible paths out of what some call a crisis.”) Harris answered some questions about the book, and the larger issues, for us. 

Retraction Watch (RW): Rigor Mortis begins with the story of the 2012 Nature paper by C. Glenn Begley and Lee Ellis that is now famous for sounding the alarm about reproducibility in basic cancer research. But as you document, this is not a problem that began in 2012. When did scientists first start realizing there was a problem? Continue reading “Failure is an essential part of science:” A Q&A with the author of a new book on reproducibility

Journals retract paper, flag two others by cancer doc under investigation

Carlo Croce

This weekend, Carlo Croce had some reprieve from the misconduct accusations that have followed him for years (recently described in a lengthy article in the New York Times) and that have prompted his university to re-open an investigation. On Sunday, he received a prestigious award from the American Association for Cancer Research, honoring his work.

But the moment may have been short-lived. Today, Croce received two expressions of concern (EOCs) from PNAS for two well-cited papers published over a decade ago, on which Croce — chair of the Department of Cancer Biology and Genetics at The Ohio State University (OSU) — is last author. The two EOCs cite concerns over duplicated bands. What’s more, another journal recently decided to retract one of his papers, citing figures that didn’t represent the results of the experiments.

PNAS chose to issue EOCs, rather than retractions or corrections, because the authors didn’t agree that the bands were duplicated, according to executive editor Diane Sullenberger. She explained how the journal learned of the issues with the two papers: Continue reading Journals retract paper, flag two others by cancer doc under investigation

Five retractions for engineering duo in South Korea over duplication, fraudulent data

An engineering student in South Korea and a professor have retracted five papers from four different journals for reasons ranging from figure duplication to manipulated or fraudulent data.

Jae Hyo Park, who is pursuing his PhD, and Seung Ki Joo, a professor in the department of material science and engineering at Seoul National University in South Korea, appear on all five papers as first and last author, respectively.

According to an official at IOP Publishing, the retractions began when a third party contacted them last March about “potential misconduct” in a paper published earlier that year in one of its journals—Journal of Physics D: Applied Physics. The IOP official Simon Davies explained: Continue reading Five retractions for engineering duo in South Korea over duplication, fraudulent data

German funder bans researcher for five years following misconduct probe

A researcher in Germany has been banned from seeking money from the largest independent research funder in the country for five years after an investigation by her former employer found her guilty of misconduct.

According to a recent announcement from the Deutsche Forschungsgemeinschaft (DFG), scientist Tina Wenz cannot apply for any DFG funding for five years, after a probe by the University of Cologne in Germany concluded she should retract six papers over misconduct.

A spokesperson for the DFG told us the agency funds more than 30,000 projects per year, and since 1998, has announced a ban due to data manipulation or misconduct only 10 times.

Continue reading German funder bans researcher for five years following misconduct probe

“Publications of questionable scientific value:” A scientist models a potential prom date

Barry Cottonfield

Eve Armstrong had an important question: How would things have turned out if she had summoned the nerve to ask a certain Barry Cottonfield to her high school’s junior prom in 1997? Continue reading “Publications of questionable scientific value:” A scientist models a potential prom date

Weekend reads: What’s the real rate of misconduct?; research parasites win awards; preprints’ watershed moment

The week at Retraction Watch featured the strange story of a reappearing retracted study, and the retraction of a study showing a link between watching violent cartoons and verbal skills. Here’s what was happening elsewhere: Continue reading Weekend reads: What’s the real rate of misconduct?; research parasites win awards; preprints’ watershed moment

Two researchers guilty of misconduct, says university investigation

Suchitra Sumitran-Holgersson

A Swedish university has concluded that two professors studying tissue engineering are guilty of misconduct in two published papers, including a 2012 study in The Lancet.

The two researchers are  Suchitra Sumitran-Holgersson and Michael Olausson, both based at the University of Gothenburg. The university investigation — launched after several of Holgersson’s papers were questioned on PubPeer — has concluded that the researchers didn’t follow proper ethical procedures in the two papers.

Here’s a statement from a university spokesperson:

Continue reading Two researchers guilty of misconduct, says university investigation

How many scientists admit to questionable research practices?

Franca Agnoli

Sure, everyone knows it’s not a good idea to falsify data. But what about somewhat lesser offenses that also undermine the reproducibility of your findings, such as only publishing studies that “work,” and reporting an unexpected finding as something you had predicted from the beginning? In 2012, a survey of more than 2,000 psychologists based in the U.S. found that most admitted to adopting at least one “questionable research practice.” But would psychologists in other countries say the same? (Answer: Yes.) A group of researchers led by Franca Agnoli at the University of Padova posed this question to 277 Italian psychologists; their results appear in PLOS ONE. 

Retraction Watch: Why is it important to compare how many researchers engage in questionable practices in different countries? 

Continue reading How many scientists admit to questionable research practices?

Cancer org bestows award on scientist under investigation

Carlo Croce

This month hasn’t been all bad for Carlo Croce. Despite issuing two corrections and being the subject of a lengthy New York Times article about how he’s dodged misconduct accusations for years (prompting his institution to re-open an investigation), Croce is now the recipient of a prestigious award from the American Association for Cancer Research.

In a recent news release, the AACR announced it was bestowing Croce the 11th Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research, named after the CEO of the AACR, for his work in the field.

According to the news release:

Continue reading Cancer org bestows award on scientist under investigation